Ann: ResApp Receives CE Mark for ResAppDx-EU, page-130

Its been a rocky journey but ResApp has finally graduated from being a science experiment to a business with a commercial product now on the market!

I wonder which telehealth company in Europe will be lining up first to sign a deal. The German Hospital trial will be kicked off imminently as they were waiting for CE clearance.

There could be a lot of catching up to do with the share price as all those ex holders who bid RAP to 55c will be looking to take a position before FDA, commercial contracts and upside into China.

We are also looking very attractive compared to PCK ($180M market cap) who just have a Class 1 product on market for a technology which was licensed off the shelf.